Vitiligo

Vitiligo is a chronic skin condition in which patches of skin lose their pigment due to the destruction of melanocytes, the cells responsible for producing skin color, resulting in irregular white patches. It can affect any part of the body, including hair and mucous membranes, and tends to be progressive, though the rate and pattern of spread vary greatly between individuals. The condition is not medically dangerous or contagious, but can have a substantial psychological and social impact given its visible nature. Vitiligo is believed to be autoimmune in origin and often occurs alongside other autoimmune conditions.

The most common symptoms include: Patchy loss of skin color; premature whitening of scalp or facial hair; loss of color in the mucous membranes inside the mouth and nose; changes in the color of the retina. Early recognition is key to prompt diagnosis and effective treatment.

No, Vitiligo is not contagious. It cannot spread through casual contact. However, certain risk factors and genetic predispositions may increase susceptibility.

Treatment options include: Treatment options include topical corticosteroids or calcineurin inhibitors to help repigment affected areas; phototherapy using narrowband UVB light; and newer targeted therapies that modulate the immune response. Camouflage cosmetics and. Treatment should always be guided by a qualified Dermatology specialist. Do not self-medicate.

While Vitiligo cannot always be fully prevented, several measures can reduce risk: No known prevention due to autoimmune basis; but sun protection to prevent burns on affected skin; early treatment to slow progression.

Consult a Dermatology specialist if symptoms persist for more than a few days, worsen despite home care, or significantly affect your daily activities. Early diagnosis leads to better outcomes.